Small-cell lung cancer: disease characteristics, treatment and novel therapeutic options

Course information

Scientific chair and author:
Prof. Solange Peters, MD, PhD
Chair of Medical Oncology
Central University Hospital (CHUV)
Lausanne

Co-authors
Prof. Sacha Rothschild, MD, PhD
Center for Oncology and Hematology
Kantonsspital Baden

Martina Imbimbo, MD
IOSI Oncology Institute of Southern Switzerland
Bellinzona

Prof. Martin Früh, MD
Medical Oncology Department
Kantonsspital St. Gallen

Chief editor:
Mag. Thomas Schindl

Teaching objective:
After completing this CME training you will be familiar with epidemiologic trends, the prognosis and classification of small-cell lung cancer, as well as principles of treatment of patients with limited and extensive disease. Innovative therapeutic options are presented that are currently being developed in clinical studies.

Primary target group(s):
Specialists in internal medicine and oncologists

Credits:
For correctly answering the multiple-choice questions – correctly answering at least 60% of the multiple-choice questions following the CME trainig – the Swiss Society of Medical Oncology awards 2 credits.

Organisation:
Universimed Cross Media Content GmbH

Sponsor:
The realisation of this CME training was financially supported by the companies Roche and PharmaMar without influencing its content.

Cost:
This CME training is provided to you free of charge

Valid until:
August 2027

Please note that you can only perform the test once.